Vaccination for hepatitis B after transplantation: A realistic goal?

Hepatology

Volumn 35, Issue 1, 2002, Pages 235-237

  Pruett, Timothy ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; LAMIVUDINE; VIRUS DNA;

ACTIVE IMMUNIZATION; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; EDITORIAL; FOLLOW UP; HEPATITIS B; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; LIVER TRANSPLANTATION; MONOTHERAPY; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; VACCINATION; VIRUS REPLICATION;

EID: 0036139960     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.31024     Document Type: Article

References (19)

1. Failure of a reinforced triple course of hepatitis B vacinnation in patients transplanted for HBV-related cirrhosis
2. Hepatitis B vaccination results in 140 liver transplant recipients
3. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease
4. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation
5. Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation
6. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers
7. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients
8. Production of antibody to hepatitis B surface antigen (anti-HBs) by murine hepatitis B virus carriers: Neonatal tolerance versus antigen presentation by dendritic cells
9. Prognostic importance of antigenpresenting dendritic cells during vaccine therapy in a murine hepatitis B virus carrier
10. Dendritic cells and chronic hepatitis virus carriers
11. The immunogenicity of influenza virus vaccine in solid organ transplant recipients
12. Efficacy of influenza vaccination in adult liver transplant recipients
13. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes
14. Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses
15. CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans
16. Higher anti-hepatitis B response with combined DTPw-HBV vaccine compared with separate administration in healthy infants at 3, 4 and 5 months of age in Slovakia
17. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice
18. Antigen-antibody complex as therapeutic vaccine for viral hepatitis B
19. Hepatitis B virus core and e antigen: Immune recognition and use as a vaccine carrier moiety